Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
61.8M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
50.6M
-
Shares change
-
+10.7M
-
Total reported value, excl. options
-
$317M
-
Value change
-
+$67.4M
-
Number of buys
-
55
-
Number of sells
-
-43
-
Price
-
$6.26
Significant Holders of Aura Biosciences, Inc. - Common Stock (AURA) as of Q2 2025
118 filings reported holding AURA - Aura Biosciences, Inc. - Common Stock as of Q2 2025.
Aura Biosciences, Inc. - Common Stock (AURA) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.6M shares
of 61.8M outstanding shares and own 81.93% of the company stock.
Largest 10 shareholders include Matrix Capital Management Company, LP (6.92M shares), Frazier Life Sciences Management, L.P. (5.1M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.88M shares), Long Focus Capital Management, LLC (4.62M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (4.37M shares), BlackRock, Inc. (3.1M shares), Medicxi Ventures Management (Jersey) Ltd (3.04M shares), VANGUARD GROUP INC (2.48M shares), FRANKLIN RESOURCES INC (2.34M shares), and Nantahala Capital Management, LLC (2.12M shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.